true

BD at ASCCP

Room Oceans 8

Friday April 24, Noon - 1:30 p.m.

Lunch will be served

Homepage banner for OnClairty
About

Join us at the 2026 ASCCP conference for an educational lunch symposium

The Connected HPV Continuum: From Prevention to Follow-Up

This symposium explores how connected tools and technologies are strengthening every stage of the HPV continuum: from prevention to patient follow‑up. We will begin with new real world HPV vaccine insights and an overview of diagnostic innovations such as the BD OnclarityTM HPV Assay, showcasing extended genotyping and self‑collection, and cutting-edge technology like mHealth (mobile health) interventions.

Dr. Emma Mitchell, PhD, RN, CPH, FAAN, will share real‑world examples of how digital tools can close follow‑up gaps, drawing on her work in Nicaragua, Appalachia and Charlottesville, Virginia. She will discuss HPV specific implementation tools designed to support patient follow up including features, such as navigation, transportation, and insurance barriers. This highlights how such tools can streamline communication, enhance adherence, and ensure continuity of care.

Together, these perspectives demonstrate how vaccines, diagnostics, and digital tools are transforming follow-up and patient retention—two of the most persistent gaps in cervical cancer prevention. Attendees will gain a forward-looking understanding of how integrated solutions reduce loss to follow-up, empower patients, and strengthen the path toward equitable cervical cancer prevention.

Save your seat for the symposium!

Also, visit table #1 to speak to an expert about BD Onclarity™ HPV Assay.

Event Speaker:  Dr. Emma Mitchell, PhD, RN, CPH, FAAN

Speaker

Dr. Emma Mitchell, PhD, RN, CPH, FAAN

 Visit table #1 to speak to an expert about BD Onclarity™ HPV Assay

Save your seat for the symposium.

Friday, April 24th, Noon – 1:30 p.m. in Room Oceans 8 

Health Care Professionals Lunch Symposium Sign-In:
I understand that BD will comply with all applicable public disclosure laws with respect to this Agreement, which mandate public disclosure of certain payments to health care practitioners/professionals. I represent and warrant that if I hold a valid license to prescribe I have indicated the correct provider ID/license number below and that if those fields are left blank I do not hold such license(s). By signing in below, I acknowledge that if there is a meal in conjuntion with this presentation/event, BD must comply with applicable public disclosure laws, and unless I indicate opt out of the meals below, BD will be allocating the appropriate portion of the meal in my name. I understand that I have the right to obtain a blank copy of this form.
VT Prescribers Only: 
Furthermore, under the Vermont Prescribed Products Gift Ban and Disclosure Law, medical device manufacturers such as BD cannot provide meals to Vermont healthcare providers (which include essentially all individual practitioners licensed to practice in Vermont). Meals, surveys, may be provided to individuals who are not Vermont healthcare providers, but information regarding the value provided should be tracked so that BD may report the value provided to federal and state agencies as required by law. 
This Agreement shall be governed by the laws of the State of New Jersey, without reference to choice or conflict of law rules otherwise applicable. 
true
ASCCP Conference Symposium Join us for an insightful presentation at ACOG as Dr. Leeya Pinder delves into the modernized, patient centered look at making cervical screening work for real patients. Event, Exhibition, Symposia, Gynecology, Obstetrics, ACOG, BD Onclarity™, HPV, Assay, Cervical Cancer In Person 2025-05-16 /content/dam/bd-assets/bd-com/en-us/images/stock-photography/GettyImages-685011181-4ladies-small.jpg